ConductScience.org, home

Paper42638735

Tuberculosis: insights into latency, treatment strategies, and the potential roles of metronidazole.

Wiker HG. Front Tuberc, 2023. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Tuberculosis: insights into latency, treatment strategies, and the potential roles of metronidazole. Papers, record 42638735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42638735

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tuberculosis: insights into latency, treatment strategies, and the potential roles of metronidazole.
PubMed
Journal
Front Tuberc
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2026-08-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wiker HGHarald G

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127296510Substantial molecular evolution and mutation rates in prolonged latent Mycobacterium tuberculosis infection in humans.Int J Med Microbiol2016https://conductscience.org/library/papers/27296510PubMed
221364979Analysis of the lung microbiome in the "healthy" smoker and in COPD.PLoS One2011https://conductscience.org/library/papers/21364979PubMed
321315848How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology.Infect Genet Evol2011https://conductscience.org/library/papers/21315848PubMed
510223954Metronidazole therapy in mice infected with tuberculosis.Antimicrob Agents Chemother1999https://conductscience.org/library/papers/10223954PubMed
68675308An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence.Infect Immun1996https://conductscience.org/library/papers/8675308PubMed
79755928Metronidazole has no antibacterial effect in Cornell model murine tuberculosis.Int J Tuberc Lung Dis1998https://conductscience.org/library/papers/9755928PubMed
823733467Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis.Antimicrob Agents Chemother2013https://conductscience.org/library/papers/23733467PubMed
921680950Topographical continuity of bacterial populations in the healthy human respiratory tract.Am J Respir Crit Care Med2011https://conductscience.org/library/papers/21680950PubMed
104903501Controlled chemoprophylaxis trials in tuberculosis. A general review.Bibl Tuberc1970https://conductscience.org/library/papers/4903501PubMed
1121575291Long-term course of Mycobacterium tuberculosis infection in Swedish birth cohorts during the twentieth century.Int J Tuberc Lung Dis2011https://conductscience.org/library/papers/21575291PubMed
1217242153Metronidazole plus rifampin sterilizes long-term dormant Mycobacterium tuberculosis.Antimicrob Agents Chemother2007https://conductscience.org/library/papers/17242153PubMed
1327780211The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.PLoS Med2016https://conductscience.org/library/papers/27780211PubMed
1418491971Metronidazole lacks activity against Mycobacterium tuberculosis in an in vivo hypoxic granuloma model of latency.J Infect Dis2008https://conductscience.org/library/papers/18491971PubMed
15356255Bovine tuberculosis in man--reinfection or endogenous exacerbation.Scand J Respir Dis1978https://conductscience.org/library/papers/356255PubMed
1611807725Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection.J Infect Dis2002https://conductscience.org/library/papers/11807725PubMed
1730139910Revisiting the timetable of tuberculosis.BMJ2018https://conductscience.org/library/papers/30139910PubMed
1824618815Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans.PLoS One2014https://conductscience.org/library/papers/24618815PubMed
199805839Action of metronidazole in combination with isoniazid & rifampicin on persisting organisms in experimental murine tuberculosis.Indian J Med Res1998https://conductscience.org/library/papers/9805839PubMed
2022895789Metronidazole validates drugs targeting hypoxic bacteria for improved treatment of tuberculosis.Proc Natl Acad Sci U S A2012https://conductscience.org/library/papers/22895789PubMed
212632532Role of metronidazole in improving response and specific drug sensitivity in advanced pulmonary tuberculosis.J Assoc Physicians India1989https://conductscience.org/library/papers/2632532PubMed

See all 29 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42638735

GET https://conductscience.org/api/papers/v1/42638735/references?page=2